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Background and purpose   Hip resurfacing arthroplasty is claimed 
to allow higher activity levels and to give better quality of life than 
total hip arthroplasty. In this literature review, we assessed the 
therapeutic value of hip resurfacing arthroplasty as measured by 
functional outcome. 
Methods   An extensive literature search was performed using 
the PubMed, Embase, and Cochrane databases. 
Results   9 patient series, 1 case-control study, and 1 random-
ized controlled trial (RCT) were included. Clinically and statisti-
cally significant improvement in sporting activity and hip scores 
were found in 10 studies. 
Interpretation   Studies with low levels of evidence have shown 
improvement in various different hip scores and one RCT showed 
better outcomes with hip resurfacing arthroplasty. There is no 
high-level evidence to prove that there is improved clinical out-
come  using  hip  resurfacing  arthroplasty.  More  randomized 
research needs to be done. 
 
During the mid-1990s, new designs of hip resurfacing arthro-
plasties (HRAs) were introduced. These implants use a metal-
on-metal bearing surface with the advantage that there is no 
polyethylene wear debris. The medium- to long-term results 
of this new generation of prosthesis seem promising, with 
few  complications  (Treacy  et  al.  2005,  Buergi  and Walter 
2007). Although these metal-on-metal bearings produce less 
wear debris, the long-term consequences of metal release are 
unknown. This is especially important since HRA is being 
used in younger individuals. Studies have shown an increase 
in plasma levels of chromium and cobalt of about 2–13 times 
for chromium and 4–7 times for cobalt (Trentani and Vacca-
rino 1981, Vendittoli et al. 2007). Furthermore, the formation 
of pseudotumors as a consequence of metal-on-metal prosthe-
ses has been reported (Mahendra et al. 2009, von Schewelov 
and Sanzén 2010).
It is claimed that patients can return to their previous activ-
ity level and even perform high-impact sports (Infozimmerdu-
rom 2008, Smith & Nephew 2008, DePuy 2008). We therefore 
investigated the evidence for this claim. We asked: “What is 
the therapeutic value of HRA in patients who have undergone 
HRA for osteoarthritis, measured by quality of life or func-
tional outcomes?” 
Methods 
In December 2008, we performed a literature search using the 
PubMed and Embase databases. The search was performed 
only on the basis of determinant, because of a limited amount 
of literature on the subject; different synonyms for resurfacing 
HRA were used (Table 1, see Supplementary data). Search 
queries were limited to Title/Abstract. Relevant studies were 
screened  for  references.  Articles  in  languages  other  then 
English, Dutch, French, or German and articles with other 
domains, determinants, or outcomes were excluded. Further 
studies were selected according to relevance and were criti-
cally appraised according to criteria developed by the Center 
for Evidence-Based Medicine, Therapy Worksheet, n.d.
Results 
The search using the PubMed, Embase and Cochrane data-
bases  yielded  245  articles  (Figure  1,  Supplementary  data). 
Screening on Title/Abstract resulted in 23 articles, and after 
exclusion of duplicates 15 articles remained. No additional 
articles  were  found  by  cross-referencing.  After  selection 
by relevance and critical appraisal, 11 articles remained for 
inclusion. Articles were considered relevant if they included 
the domain “patients with osteoarthritis”, determinant “HRA” 
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our research question. 9 studies were patient series, 1 was a 
case-control study, and 1 was a randomized controlled trial, 
which  was  ranked  highest.  3  patient  series  contained  over 
500 patients and 2 studies contained more than 200 patients. 
Median or mean follow-up was less than one year for 2 stud-
ies, 1–5 years for 5 studies (which included the randomized 
controlled trial), and > 5 years for 4 studies. All patient series 
showed good clinical outcome scores (Table 3). Pollard et al. 
(2006) found significantly better outcome scores for Birming-
ham hip replacement (BHR) than for total hip arthroplasty 
(THA). Lavigne et al. (2008) found better outcome scores for 
HRA than for THA, of which only the differences in global 
activity scores were statistically significant. Tables 2 and 3 and 
Figures 2 and 3 give an overview of the results. 
Table 2. General study data
Author  Follow-up  Mean age  Women (%)  Men (%)  Complication   Revision
Khan et al. (2009)  mean 6 (5–8) years  median 51 (16–88)  40  60  4%  29 (4.4%)
Amstutz et al. (2008)  mean 5.6 (1.1–11) years  50 (14–78)  25.3  74.4  8.1%  34 (3.4%)
Heilpern et al. (2008)  mean 71 (60–93) months  54 (35–75)  42  58  4%    4 (3.5%)
Lavigne et al. (2008)  minimum 1 year  48 (23–63)  35/28 b  65/72 b  unknown  unknown
Steffen et al. (2008)  mean 4.2 (2.0–7.6) years  52 (17–82)  41  59  3.8%  23 (3.8%)
Witzleb et al. (2008)  median 24 (2–66) months  49 (15–69)  43  57  3.4%    2 (0.8%)
Naal et al. (2007)  mean 23.5 (9–40) months  53  –  –  unknown  unknown
Narvani et al. (2006)  minimum 6 months  unknown  –  –  unknown  unknown
Pollard et al. (2006)  mean 61 (52–71) months  50 (18–67)  25/22 b  75/78 b  11(21%)/7(11%) b   1 (1.9%)/4 (6.3%) b
Back et al. (2005)  median 36 (25–52) months  52 (18–82)  35  65  10% a (5.6%)    1 (0.43%)
McMinn et al. (1996)  mean 8.3 (1–19) months  unknown  –  –  unknown    0
a superficial wound infections included.
b THA/HRA
Table 3. Results of clinical scores
Author  Preoperative  Follow-up   
  UCLA score  HHS  Other scores  UCLA score  HHS  Other scores
Khan et al. (2009)    47      95 (84–100) 1-yr  DAS 6 (5–6)   
          88 (77–100) 8-yr  95% extremely 
            satisfied at 7 years
Amstutz et al. (2008)  3.6 (SD 1.2) pain;    9.4 (SD 0.9) pain;
   6.4 (SD 1.4) walking;    9.6 (SD 0.9) walking;
  5.8 (SD 1.6) function;    9.5 (SD 1.2) function;
  4.7 (SD 1.5) activity    7.5 (SD 1.6) activity 
Heilpern et al. (2008)  3.9 (1–10)    OHS 41.9 (16–57)  7.5 (4–10)  96.4 (53–100)  OHS 15.4 (12–49)
Lavigne et al. (2008)      GAS HRA 5.8   HRA 7.1    GAS HRA 17.9
       GAS THA 5.1  THA 6.75    GAS THA 12.4
            WOMAC HRA 8.1
            WOMAC THA 9.8
Steffen et al. (2008)        6.6 (SD 1.9)    OHS 16.1 (SD 7.7)
Witzleb et al. (2008)    51 (44–60)      96 (85–100)
Naal et al. (2007)      4.8 (SD 2.3)      4.6 (SD 1.9)
       different sports      sports (NS)
            85% excellent/good
Narvani et al. (2006)    48 (30–67)  65% sports    92 (30–97)  92% sports
       participation      participation
Pollard et al. (2006)        THA 7 (3–10)     Sports: THA 33.3% 
        HRA 9 (4–10)                HRA 73.6%
            EQ-VAS: THA 69.3
                           HRA 82.3
Back et al. (2005)    CA 63.9 (8–93);  SF12 31.1; 58.6    97.7 (60–100)  SF12 54.1; 56.9
    CB 56.2 (18–82);  SF12 30.3; 60.5    99.4 (90–100)  SF12 54.1; 57.7    
    CC 64.4 (30–98)  SF12 31.5; 52.2    85.5 (30–100)  SF12 48.2; 55.9   
McMinn et al. (1996)      Charnley scores:      
       Pain 3      Pain 5.4     
      Mobility 3.1      Mobility 5.4
      Walking 3.3      Walking 5.4682  Acta Orthopaedica 2010; 81 (4): 680–683
Discussion 
In every study, patients and clinicians knew which prosthe-
sis was used; therefore, all studies were subject to certain 
degrees of bias, most of all confounder bias since validated 
outcome scores were not used. The study of Pollard et al. 
(2006) was a case-control study but they restricted patients 
who received THA in their activities. This also introduces 
bias. The studies by Amstutz and Le Duff (2008) and Khan 
et al. (2009) received funding from industry-related compa-
nies and institutions. As with any new complex surgical tech-
nique, there is a learning curve associated with the surgeon’s 
technical  ability  to  perform  the  procedure. A  publication 
bias may therefore exist, as only surgeons at the top of their 
learning curve, operating regularly, would obtain sufficient 
numbers to warrant publication of their cases. Finally, our 
review suffers from the same publication bias that all litera-
ture reviews are subject to: negative findings are less likely 
to be published. 
  The studies included quoted variable complication rates 
ranging from 3% to 10%. This 3-fold difference can be partly 
explained  by  the  different  definitions  used  by  the  authors 
regarding  what  constituted  a  complication.  Only  4  of  the 
studies had a follow-up period of longer than 5 years. Revi-  Revi-
sion rates were also reported by Khan et al. (2009) as 4%, by 
Amstutz and Le Duff (2008) as 3%, by Heilpern et al. (2008) 
as 4%, by Steffen et al. (2008) as 4%, by Witzleb et al. (2008) 
as 0.8%, by Pollard et al. (2006) as 2% for THA and 6% for 
HRA, by Back et al. (2005) as 0.4%, and by McMinn et al. 
(1996) as 0% (Table 4). Although not part of our study aim, 
these numbers suggest relatively high revision rates with short 
follow-up. In a study performed by Hallan et al. (2007) on 
uncemented THA with a minimum follow-up time of 7 years 
and an endpoint of revision of aseptic loosening of the stem, 
the survival was between 96% and 100% at 10 years. So com-
plication and revision rates in the studies included are already 
relatively high. We can only assume that complication rates 
would be higher with longer follow-up. The literature on THA 
suggests that augmented revision rates in this type of surgery 
only start to rise after 7 years.
The use of different clinical outcome scores and the differ-
ences in the duration of follow-up make direct comparison 
between studies difficult. A combination of the University of 
California Los Angeles activity scale (UCLAS) and Harris hip 
score (HHS) was used in 5 studies as follow-up scores, but 
UCLAS was only used in 1 study preoperatively and HHS in 
4 (Table 3). We found only 2 studies that directly compared 
HRA with THA. Reviewing the available literature, there is 
evidence that HRA has a better outcome than THA (as meas-
ured by HHS or UCLAS). Beaulé et al. (2006) performed a 
study on 152 patients who underwent THA with an average 
age of 59 (21–87) years, and an average follow-up of 5 (2–21) 
years. They found a mean HHS of 89 (SD 14) (range: 40–100) 
and mean UCLAS score was 6.8 (2–10). Similar outcome 
scores were found by Moran et al. (2004) (with a mean HHS 
of 85 (SD 14) for consultants and of 85 (SD 14) for train-
ees) and by Lieberman et al. (1997) (with a mean HHS of 85 
(26–100)).
  
Conclusion 
Our review shows that HRA does have a good clinical out-
come with respect to function in the short to medium term, 
based on data from the 11 available studies. However, the 
level of this evidence is generally poor with most studies (9) 
being level 4. Pollard et al. (2006) restricted the activity of 
the control (THA) group, leading to a distinct possibility of 
bias. Only 1 study was a randomized controlled trial (Level 
1c) involving 209 hips. The functional outcome measures of 
HHS and UCLAS appear to convey a clinically significant 
improvement compared to those found in the literature for 
THA, but there have been very few studies that performed 
a direct comparison between the two treatment modalities. 
The clinical outcomes of revision rates and complications are 
surprisingly high in some of the studies identified here, with 
relatively short follow-up. Long-term results from these stud-
ies are eagerly awaited, to see whether the benefits identified 
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withstand the test of time as robustly as those of THA without 
a disproportionately high revision rate over a similar follow-
up period. 
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Supplementary Figure 1 and Table 1 are available at our web-
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